Pre-Clinical T Cell Immunotherapy Strategies For Overcoming Immunosuppression In Solid Tumors

Pre-clinical T cell immunotherapy strategies for overcoming immunosuppression in solid tumors

Using genetically engineered preclinical models to study T cell therapy against solid tumors

Enhancing CAR-T cell efficacy in solid tumors

Barriers to using CAR T-cells in solid tumors and strategies to overcome them

New Concepts in Immunotherapy for Solid Tumors

PeerView Oncology

Strategies to improve CAR T-cells in solid tumors

VJHemOnc – Video Journal of Hematology & HemOnc

Overcoming the challenges faced with cellular therapies in solid tumors

P329G-targeting CAR-T cells designed to target solid tumors

Immunotherapy & CAR T Cells: Part 2

Cell Signaling Technology, Inc.

Developing a new generation of CAR T-cell therapies for solid tumors

Improving Immunotherapy Strategies for Cancers

NCI Scientific Events and Resources

Challenges associated with CAR-T cells in solid tumors

Anti-HER2 CAR macrophages for solid tumors

CAR T Cell Immunotherapy of Solid Tumors Learning from the Clinic and Lab in Parallel

Treating HER2-positive solid tumors with TAC T-cell therapy

Cellular Immunotherapies: Revving Up T Cells to Fight Cancer, with Philip Greenberg, M.D.

Cancer Research Institute

2023 FIRST LOOK | Angela Shen, MD / Marcela Maus, MD, PhD

World Medical Innovation Forum

Webinar: Engineering strategies for improving adoptive T cell therapy against cancer

Creative Biolabs

Challenges of CAR T-cell therapy for solid cancers

VJHemOnc – Video Journal of Hematology & HemOnc

Promoting the functional persistence of CAR-T cells in solid tumors via immune checkpoint blockade